Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 AUD | -2.33% | +9.09% | +21.74% |
Apr. 30 | Canaccord Starts Immutep at Buy, Price Target is AU$1.00 | MT |
Apr. 24 | Immutep Shows Positive Data in Trial to Treat Squamous Cell Cancers in Head, Neck | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.74% | 332M | |
-0.17% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.61% | 24.63B | |
-23.35% | 18.2B | |
+26.87% | 12.01B | |
-3.02% | 11.76B | |
+14.32% | 10.4B | |
-3.68% | 9.94B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Immutep Taps Center for Human Drug Research for IMP761 Human Clinical Trial